Literature DB >> 18344689

Predictors of left ventricular thrombus formation in acute myocardial infarction treated with successful primary angioplasty with stenting.

Marzenna Zielinska1, Krzysztof Kaczmarek, Michał Tylkowski.   

Abstract

BACKGROUND: There are limited data referring to the incidence of left ventricle (LV) thrombus formation after successful primary percutaneous coronary intervention (PCI) with stenting, which is now the treatment of choice in patients with acute myocardial infarction (AMI). Previously reported results were often based on low or heterogeneous patient populations.
METHODS: To evaluate the prevalence of LV thrombus in the early period of AMI, 2,911 patients who had undergone successful primary stenting were retrospectively studied. Baseline demographic characteristics, angiographic findings, and antiplatelet treatment were analyzed to find predictors of thrombus formation. LV thrombus was diagnosed by 2-dimensional echocardiography within 3 to 5 days after PCI.
RESULTS: This complication was detected in 73 patients (2.5%). Patients with thrombus and patients without it were at the same age and had diabetes mellitus, prior myocardial infarction, and lipid disorders at the same frequency. The extent of coronary artery disease was similar in both groups. The incidence of LV thrombi was similar in patients treated with and without glycoprotein IIb/IIIa inhibitors (2.02% vs 2.9%, NS). According to results of multiple log-regression analysis, the presence of LV thrombus was strongly associated with anterior AMI, ejection fraction <40%, and previous hypertension.
CONCLUSIONS: The incidence of left ventricular thrombus early after AMI is very low if primary PCI with stenting is successful, probably due to the salvage of myocardium at risk. Localization of AMI and the size of myocardium damage remain the most important independent predictors of LV thrombus formation irrespective of various treatments.

Entities:  

Mesh:

Year:  2008        PMID: 18344689     DOI: 10.1097/MAJ.0b013e318142be20

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  14 in total

1.  Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series.

Authors:  Keaton S Smetana; Jessie Dunne; Kevin Parrott; George A Davis; Amy C Schmelzer Collier; Mary Covell; Susan Smyth
Journal:  J Thromb Thrombolysis       Date:  2017-11       Impact factor: 2.300

2.  Successful surgical transmitral removal of left ventricular thrombus after acute anterior myocardial infarction without left ventriculotomy.

Authors:  Daigo Takahashi; Hideki Wada; Manabu Ogita; Taketo Sonoda; Keiichi Tambara; Satoru Suwa; Hiroyuki Daida
Journal:  J Cardiol Cases       Date:  2020-09-04

3.  Clinical predictors and outcomes of patients with left ventricular thrombus following ST-segment elevation myocardial infarction.

Authors:  Adam M Garber; Robert J Mentz; Hussein R Al-Khalidi; Linda K Shaw; Mona Fiuzat; Christopher M O'Connor; Eric J Velazquez
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

4.  In-hospital left ventricular thrombus following ST-elevation myocardial infarction.

Authors:  Aiham Albaeni; Khaled Chatila; Hind A Beydoun; May A Beydoun; Mohammad Morsy; Wissam I Khalife
Journal:  Int J Cardiol       Date:  2019-07-23       Impact factor: 4.164

5.  Abciximab and left ventricular thrombus formation in early period of acute myocardial infarction treated with successful primary stenting.

Authors:  Marzenna Zielinska; Krzysztof Kaczmarek
Journal:  J Thromb Thrombolysis       Date:  2008-05-04       Impact factor: 2.300

6.  Sequential thromboembolic events after primary angioplasty in a patient with acute anterior myocardial infarction.

Authors:  Constantina Aggeli; Panagiota Pietri; Manolis Vavouranakis; Ioannis Felekos; Hraklis Tatsis; Christodoulos Stefanadis
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-12

7.  Relationship of left ventricular thrombus formation and adverse outcomes in acute anterior myocardial infarction in patients treated with primary percutaneous coronary intervention.

Authors:  Qian Zhang; Chun-Mei Wang; Shu-Tian Shi; Hong Chen; Yu-Jie Zhou
Journal:  Clin Cardiol       Date:  2018-11-30       Impact factor: 2.882

8.  Dabigatran Added to Dual Antiplatelet Therapy to Treat a Left Ventricular Thrombus in an 87 Year Old Patient With Myocardial Infarction and Very High Bleeding Risk.

Authors:  Maria Noflatscher; Nicolas Moes; Eva-Maria Gassner; Peter Marschang
Journal:  Front Pharmacol       Date:  2018-04-04       Impact factor: 5.810

9.  Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy.

Authors:  Svein Solheim; Ingebjørg Seljeflot; Ketil Lunde; Vibeke Bratseth; Svend Aakhus; Kolbjørn Forfang; Harald Arnesen
Journal:  Thromb J       Date:  2013-01-11

10.  Outcomes and Prognostic Impact of Prophylactic Oral Anticoagulation in Anterior ST-Segment Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction.

Authors:  Jay S Shavadia; Erik Youngson; Kevin R Bainey; Jeffrey Bakal; Robert C Welsh
Journal:  J Am Heart Assoc       Date:  2017-07-03       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.